Need an investment idea? Check out Popular Stocks and S2O Stock Screener.

Market Price

61.87 

0.17 0.3%

as of Aug 19 '19

52 Week Range:

55.59 71.74


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands. It also provides analgesics; footcare and footwear products; sore throat medications; and women's beauty products under the Nurofen, Scholl, Strepsils, and Veet brand. In addition, the company offers fragrances and devices; water softeners; home cleaning products; dish washes; toilet bowl cleaners; disinfectants; sprays, baits, and plug-ins for pest control; stain removals; and fabric washing products under the Air Wick, Calgon, Cillit Bang, Finish, Harpic, Lysol, Mortein, Vanish, and Woolite brands, as well as infant and child nutrition products under the Enfamil and Nutramigen brands. It operates in the United States, Canada, Europe, Russia/CIS, Turkey, Israel, Australia, New Zealand, and internationally. The company was founded in 1823 and is headquartered in Slough, the United Kingdom.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Earnings BIT 2,135.00
2,177.00
2,366.00
2,630.00
3,113.00
3,356.00
growth rate 2.0% 8.7% 11.2% 18.4% 7.8%
Avg.PE 14.13
27.21
0.31
6.56
20.21
growth rate 92.6% -98.9% 2,016.1% 208.1%
Balance Sheet Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 1,403.00
1,373.00
1,272.00
1,329.00
1,302.00
1,597.00
1,996.00
2,075.00
growth rate -2.1% -7.4% 4.5% -2.0% 22.7% 25.0% 4.0%
Acct.Payable 1,002.00
948.00
991.00
990.00
981.00
1,243.00
1,770.00
1,798.00
growth rate -5.4% 4.5% -0.1% -0.9% 26.7% 42.4% 1.6%
Cur.Assets 2,938.00
3,057.00
2,901.00
3,160.00
2,882.00
3,450.00
5,424.00
4,952.00
growth rate 4.1% -5.1% 8.9% -8.8% 19.7% 57.2% -8.7%
Total Assets 14,126.00
15,066.00
15,149.00
15,496.00
15,268.00
18,019.00
37,013.00
37,650.00
growth rate 6.7% 0.6% 2.3% -1.5% 18.0% 105.4% 1.7%
Cash 639.00
887.00
808.00
917.00
740.00
882.00
2,125.00
1,483.00
growth rate 38.8% -8.9% 13.5% -19.3% 19.2% 140.9% -30.2%
Inventory 758.00
735.00
746.00
745.00
681.00
770.00
1,201.00
1,276.00
growth rate -3.0% 1.5% -0.1% -8.6% 13.1% 56.0% 6.2%
Cur.Liabilities 5,700.00
6,463.00
5,661.00
5,289.00
5,039.00
5,401.00
6,576.00
7,614.00
growth rate 13.4% -12.4% -6.6% -4.7% 7.2% 21.8% 15.8%
Liabilities 8,345.00
9,144.00
8,813.00
8,662.00
8,362.00
9,593.00
23,440.00
22,861.00
growth rate 9.6% -3.6% -1.7% -3.5% 14.7% 144.3% -2.5%
LT Debt 595.00
634.00
671.00
804.00
11,527.00
9,670.00
growth rate 6.6% 5.8% 19.8% 1,333.7% -16.1%
Equity 6,334.00
6,832.00
6,904.00
8,421.00
13,533.00
14,742.00
growth rate 7.9% 1.1% 22.0% 60.7% 8.9%
Common Shares 74.00
74.00
74.00
74.00
74.00
74.00
growth rate 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 164.00
166.00
199.00
157.00
154.00
176.00
286.00
342.00
growth rate 1.2% 19.9% -21.1% -1.9% 14.3% 62.5% 19.6%
Cash Dividends 992.00
988.00
924.00
1,035.00
1,134.00
1,187.00
growth rate -0.4% -6.5% 12.0% 9.6% 4.7%
Cash From OA 1,740.00
1,888.00
2,121.00
2,099.00
1,784.00
2,422.00
2,491.00
2,454.00
growth rate 8.5% 12.3% -1.0% -15.0% 35.8% 2.9% -1.5%
Sale Purchase of Stock 139.00
112.00
74.00
79.00
94.00
growth rate -19.4% -33.9% 6.8% 19.0%
FCF 1,576.00
1,722.00
1,922.00
1,942.00
1,630.00
2,246.00
2,205.00
2,112.00
growth rate 9.3% 11.6% 1.0% -16.1% 37.8% -1.8% -4.2%
Income Statement Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 9,485.00
9,567.00
9,266.00
8,836.00
8,874.00
9,480.00
11,449.00
12,597.00
growth rate 0.9% -3.2% -4.6% 0.4% 6.8% 20.8% 10.0%
Op.Income 1,754.00
1,825.00
2,135.00
2,177.00
2,366.00
2,630.00
3,113.00
3,356.00
growth rate 4.1% 17.0% 2.0% 8.7% 11.2% 18.4% 7.8%
IBT 1,856.00
2,126.00
2,208.00
2,253.00
2,499.00
2,722.00
growth rate 14.6% 3.9% 2.0% 10.9% 8.9%
Net Income 1,754.00
1,825.00
1,739.00
3,223.00
1,743.00
1,832.00
6,172.00
2,161.00
growth rate 4.1% -4.7% 85.3% -45.9% 5.1% 236.9% -65.0%
Gross Profit 5,449.00
5,538.00
5,258.00
5,096.00
5,246.00
5,801.00
6,982.00
7,635.00
growth rate 1.6% -5.1% -3.1% 2.9% 10.6% 20.4% 9.4%
R&D 152.00
146.00
140.00
149.00
187.00
223.00
growth rate -4.0% -4.1% 6.4% 25.5% 19.3%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 643.00
703.00
703.00
growth rate 3.0% 0.0%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 2,011.00
2,075.00
2,075.00
2,139.00
2,139.00
growth rate 3.2% 0.0% 3.1% 0.0%
Acct.Payable 4,662.00
1,798.00
1,798.00
5,958.00
5,958.00
growth rate -61.4% 0.0% 231.4% 0.0%
Cur.Assets 4,877.00
4,952.00
4,952.00
5,263.00
5,263.00
growth rate 1.5% 0.0% 6.3% 0.0%
Total Assets 36,784.00
37,650.00
37,650.00
38,582.00
38,582.00
growth rate 2.4% 0.0% 2.5% 0.0%
Cash 1,542.00
1,483.00
1,483.00
1,713.00
1,713.00
growth rate -3.8% 0.0% 15.5% 0.0%
Inventory 1,261.00
1,276.00
1,276.00
1,334.00
1,334.00
growth rate 1.2% 0.0% 4.6% 0.0%
Cur.Liabilities 7,218.00
7,614.00
7,614.00
8,987.00
8,987.00
growth rate 5.5% 0.0% 18.0% 0.0%
Liabilities 22,990.00
22,861.00
22,861.00
24,107.00
24,107.00
growth rate -0.6% 0.0% 5.5% 0.0%
LT Debt 10,357.00
9,670.00
9,670.00
9,540.00
9,540.00
growth rate -6.6% 0.0% -1.3% 0.0%
Equity 13,753.00
14,742.00
14,742.00
14,431.00
14,431.00
growth rate 7.2% 0.0% -2.1% 0.0%
Common Shares 74.00
74.00
74.00
74.00
74.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 69.50
65.50
65.50
65.50
65.50
growth rate -5.8% 0.0% 0.0% 0.0%
Cash Dividends 344.00
354.50
354.50
354.50
354.50
growth rate 3.1% 0.0% 0.0% 0.0%
Cash From OA 542.50
545.50
545.50
545.50
545.50
growth rate 0.6% 0.0% 0.0% 0.0%
Sale Purchase of Stock 32.50
growth rate
FCF 473.00
480.00
480.00
480.00
480.00
growth rate 1.5% 0.0% 0.0% 0.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 3,069.00
3,120.00
3,120.00
growth rate 0.6% 0.0%
Op.Income 643.00
703.00
703.00
703.00
703.00
growth rate 9.3% 0.0% 0.0% 0.0%
IBT 556.50
631.00
631.00
631.00
631.00
growth rate 13.4% 0.0% 0.0% 0.0%
Net Income 431.00
56.00
56.00
growth rate -49.4% 0.0%
Gross Profit 1,855.00
1,878.50
1,878.50
growth rate 0.4% 0.0%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (36.41)

YOY Growth Grade:

E (25.75)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 30.97 31.06 0.17
EPS / Growth 4.0% 1.99 6.4%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 21.9%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 4.0% 10.8% 10.8%
Future PE 0.17 17.56 17.56
Future EPS 2.94 5.54 5.54
Value Price
MOS %
0.13
-99.8%
24.05
-61.1%
24.05
-61.1%
MOS Price 0.06 12.02 12.02
IRT 20.10 13.59 13.59

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.